source
- Proposal to start medical school after Step 1 exam to cut debt and boost diversityThe authors, bioethicists at SUNY Upstate Medical University, argue that medical education should be split into two distinct phases. The first phase would cover the pre‑clinical sciences that are t…
- STAT+: FDA rejects lung cancer treatment ivonescimab from Summit TherapeuticsThe FDA has rejected ivonescimab, a treatment for a type of lung cancer developed by U.S. biotech Summit Therapeutics and the Chinese drugmaker Akeso.STAT · 4d ago↗ source
- FDA issues complete response letter, rejecting Summit Therapeutics' ivonescimab for EGFR-mutated lung cancer